Oracle (ORCL) PT Raised to $185 at Piper Sandler

Piper Sandler analyst Brent Bracelin raised the price target on Oracle (NYSE: ORCL) to $185.00 (from $175.00) while maintaining a Overweight rating.

The analyst commented, "We are raising our PT to $185 from $175 just four days after our post earnings adjustments factoring in a bold and ambitious F29 revenue marker of $104B (vs. $53B in F24) and the F26 revenue raise to $66B+ (vs. $65B prior). This veteran and proven leadership team clearly has increasing confidence in the underlying drivers of a top-line recovery led by cloud and AI secular drivers. Prospects of a multi-quarter reacceleration that could evolve into a multi-year acceleration warrant multiple expansion, in our view. Our new PT assumes a CY26E P/E of 24x (vs. 23x prior) on slightly higher growth and margin assumptions. Reiterate Overweight."

You May Also Be Interested In